Answers are grounded in this paper and cite their sources.
Living probiotics are receiving considerable attention in serving as biosafe and superb antibacterial agents for infected wound healing. However, the inadequate reactive oxygen species (ROS) scavenging capacity compromises the therapeutic effect of probiotics for infected diabetic wounds with high oxidative stress. Herein, we develop a nanozyme-fortified probiotic (NFP) orchestrating an excellent antioxidative activity and broad-spectrum antibacterial properties for synergistic living therapeutics of infected diabetic wounds. The Cu-doped zinc metal–organic framework (CDN) is synthesized to provide a bimetallic biomimetic Cu/Zn site and is uniformly anchored on the surface of Lacticaseibacillus rhamnosus GG (LGG). The resultant NFP exhibits four types of enzyme-like catalytic activities for ROS scavenging and demonstrates an excellent antioxidant capability. The superior intracellular antioxidant and anti-inflammatory effects of NFP are also perceived, ascribed to the regulation of cytokine–cytokine receptor interaction, arachidonic acid metabolism, and signaling by interleukins in the cell. The secretion promotion of antimicrobial short-chain fatty acids is triggered by CDN regulation for the physiological activities of LGG, eliciting the well-balanced antibacterial activity of NFP. As demonstrated by the rat model of infected diabetic wounds, application of NFP significantly eradicates bacterial infection, alleviates inflammation by ROS elimination, and directs polarization to M2 macrophages, thereby accelerating wound closure. This work provides a promising living material-based tactic consisting of microbial therapy and catalytic nanomaterials for treating infected diabetic wounds.
No takes yet. Share an insight, caveat, or question.
Han et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: